JP2018076353A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018076353A5 JP2018076353A5 JP2017248953A JP2017248953A JP2018076353A5 JP 2018076353 A5 JP2018076353 A5 JP 2018076353A5 JP 2017248953 A JP2017248953 A JP 2017248953A JP 2017248953 A JP2017248953 A JP 2017248953A JP 2018076353 A5 JP2018076353 A5 JP 2018076353A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- formula
- dideoxy
- acetamido
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- KEPASPNPCAOJNB-UHFFFAOYSA-N NC1C(C#N)=CC(C#N)=CC1CNC(CC1)CCC1O Chemical compound NC1C(C#N)=CC(C#N)=CC1CNC(CC1)CCC1O KEPASPNPCAOJNB-UHFFFAOYSA-N 0.000 description 2
- ZJYSHVCOUMQIDV-UHFFFAOYSA-N CCC(C)CC/[O]=C(\C)/Nc(c(CN(C)C1CCCCC1)cc(Br)c1)c1Br Chemical compound CCC(C)CC/[O]=C(\C)/Nc(c(CN(C)C1CCCCC1)cc(Br)c1)c1Br ZJYSHVCOUMQIDV-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11010078.1 | 2011-12-22 | ||
| EP11010078 | 2011-12-22 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014547767A Division JP6320931B2 (ja) | 2011-12-22 | 2012-12-21 | リソソーム酵素を再構成する能力を有する化合物ならびにアンブロキソールおよび／またはアンブロキソールの誘導体の組み合わせ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018076353A JP2018076353A (ja) | 2018-05-17 |
| JP2018076353A5 true JP2018076353A5 (https=) | 2018-07-19 |
Family
ID=47559375
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014547767A Expired - Fee Related JP6320931B2 (ja) | 2011-12-22 | 2012-12-21 | リソソーム酵素を再構成する能力を有する化合物ならびにアンブロキソールおよび／またはアンブロキソールの誘導体の組み合わせ |
| JP2017248953A Pending JP2018076353A (ja) | 2011-12-22 | 2017-12-26 | リソソーム酵素を再構成する能力を有する化合物ならびにアンブロキソールおよび／またはアンブロキソールの誘導体の組み合わせ |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014547767A Expired - Fee Related JP6320931B2 (ja) | 2011-12-22 | 2012-12-21 | リソソーム酵素を再構成する能力を有する化合物ならびにアンブロキソールおよび／またはアンブロキソールの誘導体の組み合わせ |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20150258081A1 (https=) |
| EP (1) | EP2793872B1 (https=) |
| JP (2) | JP6320931B2 (https=) |
| KR (1) | KR102076585B1 (https=) |
| AU (2) | AU2012359165A1 (https=) |
| BR (1) | BR112014014808A2 (https=) |
| CA (1) | CA2860085A1 (https=) |
| ES (1) | ES2864774T3 (https=) |
| IL (1) | IL233173B (https=) |
| WO (1) | WO2013091897A1 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9675627B2 (en) * | 2014-04-14 | 2017-06-13 | Amicus Therapeutics, Inc. | Dosing regimens for treating and/or preventing cerebral amyloidoses |
| CN114540327B (zh) | 2014-09-30 | 2026-03-24 | 阿米库斯治疗学公司 | 具有增强的碳水化合物的高强度酸性α-葡糖苷酶 |
| GB201508025D0 (en) | 2015-05-11 | 2015-06-24 | Ucl Business Plc | Fabry disease gene therapy |
| JP6981961B2 (ja) * | 2015-07-30 | 2021-12-17 | ホライズン オルファン エルエルシー | フコシダーゼ阻害剤 |
| KR20250007693A (ko) | 2015-12-30 | 2025-01-14 | 아미쿠스 세라퓨틱스, 인코포레이티드 | 폼페병 치료용의 강화된 산 알파-글루코시다제 |
| KR20190087673A (ko) | 2016-03-22 | 2019-07-24 | 아미쿠스 세라퓨틱스, 인코포레이티드 | Ｇｌａ 유전자에 ｇ9331ａ 돌연변이를 갖는 환자에서 파브리 질병의 치료 방법 |
| CA3019354A1 (en) | 2016-03-30 | 2017-10-05 | Amicus Therapeutics, Inc. | Method for selection of high m6p recombinant proteins |
| AU2017239641A1 (en) | 2016-03-30 | 2018-10-18 | Amicus Therapeutics, Inc. | Formulations comprising recombinant acid alpha-glucosidase |
| US20190254992A1 (en) * | 2016-06-29 | 2019-08-22 | Hadasit Medical Research Services & Development Limited | Combinations of beta-glycolipides and 4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol, compositions and uses thereof in the treatment of disorders associated with protein misfolding and protein aggregations |
| WO2018089797A1 (en) * | 2016-11-14 | 2018-05-17 | Mingwu Wang | Formulations for the treatment of ocular surface diseases and related methods |
| CN110573492A (zh) * | 2017-04-25 | 2019-12-13 | 阿米库斯治疗学公司 | 用于预防和/或治疗中枢神经系统退行性失调和/或溶酶体贮积失调的新颖组合物 |
| SMT202300187T1 (it) | 2017-05-15 | 2023-07-20 | Amicus Therapeutics Inc | Alfa-glucosidasi acida umana ricombinante |
| CA3224546C (en) | 2017-05-30 | 2026-02-24 | Amicus Therapeutics, Inc. | Use of migalastat in the treatment of fabry patients |
| US20220184185A1 (en) | 2018-07-25 | 2022-06-16 | Modernatx, Inc. | Mrna based enzyme replacement therapy combined with a pharmacological chaperone for the treatment of lysosomal storage disorders |
| US12594268B2 (en) | 2018-08-20 | 2026-04-07 | Amicus Therapeutics, Inc. | Methods of treating Fabry disease in patients having a mutation in the GLA gene |
| US11612619B2 (en) | 2018-11-01 | 2023-03-28 | National Institute Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government | Compostions and methods for enabling cholesterol catabolism in human cells |
| EP3884383B1 (en) * | 2018-12-21 | 2025-04-16 | Shenzhen Yinwang Intelligent Technologies Co., Ltd. | Data deterministic deliverable communication technology based on qos as a service |
| WO2020168294A1 (en) * | 2019-02-15 | 2020-08-20 | Lysosomal And Rare Disorders Research And Treatment Center, Llc | Methods and compositions for treating lysosomal storage disorders: ambroxol as treatment agent for mucopolysaccharidoses iii (sanfilippo syndrome) |
| EP3996696A1 (en) * | 2019-07-09 | 2022-05-18 | Genethon | Treatment of glycogen storage disease (gsd) |
| KR20220044560A (ko) | 2019-08-07 | 2022-04-08 | 아미쿠스 세라퓨틱스, 인코포레이티드 | Gla 유전자에 돌연변이를 갖는 환자에서 파브리 질병을 치료하는 방법 |
| US12544402B2 (en) | 2020-02-28 | 2026-02-10 | Repair Biotechnologies, Inc. | Targeted expression of microbial cholesterol catalysis genes reduces excess lipid |
| CN112773779B (zh) * | 2021-02-04 | 2022-08-16 | 上海交通大学医学院附属新华医院 | 氨溴索、千金藤和汉防已在治疗酸性鞘磷脂酶缺乏症中的应用 |
| CN114644572B (zh) * | 2022-03-22 | 2023-03-28 | 华南农业大学 | 一种溴己新半抗原、人工抗原、抗体及其制备方法和应用 |
| KR20260002803A (ko) * | 2023-05-02 | 2026-01-06 | 지위, 엘엘씨 | 치료적 사용을 위한 암브록솔의 변형된 형태 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19933148A1 (de) | 1999-07-20 | 2001-01-25 | Boehringer Ingelheim Int | Ambroxolhaltige Lutschtablette |
| EP2857036B1 (en) * | 2003-01-31 | 2016-12-21 | Mount Sinai School of Medicine of New York University | Combination therapy for treating protein deficiency disorders |
| PL2533050T6 (pl) * | 2006-05-16 | 2016-05-31 | Amicus Therapeutics Inc | Możliwości leczenia choroby Fabry'ego |
| JP5337405B2 (ja) * | 2007-09-17 | 2013-11-06 | ザ・ホスピタル・フォー・シック・チルドレン | ゴーシェ病の治療方法 |
| CA2718182A1 (en) * | 2008-03-12 | 2009-09-17 | Amicus Therapeutics, Inc. | Treatment of pompe disease with specific pharmacological chaperones and monitoring treatment using surrogate markers |
| EP2353403B1 (de) * | 2010-02-01 | 2012-07-11 | Symrise AG | Verwendung von 1-(2,4-Dihydroxy-phenyl)-3-(3-hydroxy-4-methoxy-phenyl)-propan-1-on |
-
2012
- 2012-12-21 KR KR1020147019849A patent/KR102076585B1/ko not_active Expired - Fee Related
- 2012-12-21 US US14/367,835 patent/US20150258081A1/en not_active Abandoned
- 2012-12-21 CA CA2860085A patent/CA2860085A1/en not_active Abandoned
- 2012-12-21 EP EP12815644.5A patent/EP2793872B1/en not_active Not-in-force
- 2012-12-21 AU AU2012359165A patent/AU2012359165A1/en not_active Abandoned
- 2012-12-21 ES ES12815644T patent/ES2864774T3/es active Active
- 2012-12-21 JP JP2014547767A patent/JP6320931B2/ja not_active Expired - Fee Related
- 2012-12-21 WO PCT/EP2012/005363 patent/WO2013091897A1/en not_active Ceased
- 2012-12-21 BR BR112014014808A patent/BR112014014808A2/pt not_active Application Discontinuation
-
2014
- 2014-06-16 IL IL233173A patent/IL233173B/en active IP Right Grant
-
2017
- 2017-12-22 AU AU2017279780A patent/AU2017279780B2/en not_active Ceased
- 2017-12-26 JP JP2017248953A patent/JP2018076353A/ja active Pending
-
2021
- 2021-04-05 US US17/222,254 patent/US20210228560A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018076353A5 (https=) | ||
| JP2026035578A (ja) | ファブリー病の治療用投薬レジメン | |
| JP5657565B2 (ja) | Ｓ１ｐ受容体アゴニストの投与レジメン | |
| ES2980828T3 (es) | Pautas posológicas para el tratamiento de enfermedad de Pompe | |
| TWI611803B (zh) | 投與吡非尼酮(pirfenidone)療法之方法 | |
| JP2015502964A5 (https=) | ||
| US20050154009A1 (en) | Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor | |
| US20100152108A1 (en) | Methods and combination therapies for treating alzheimer's disease | |
| US20080139511A1 (en) | Combination Therapies Employing Ace Inhibitors and Uses Thereof for the Treatment of Diabetic Disorders | |
| US9561232B2 (en) | Low dose noribogaine for treating nicotine addiction and preventing relapse of nicotine use | |
| US20060035864A1 (en) | Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders | |
| JP2013505983A5 (https=) | ||
| MXPA06012116A (es) | Uso de flibanserina en el tratamiento del trastornos premestruales y otros trastornos sexuales femeninos. | |
| JP6174666B2 (ja) | ナルトレキソンの徐放型配合物 | |
| US20220288048A1 (en) | Pimavanserin for treating schizophrenia or for treating psychosis secondary to neurodegenerative disorders or depressive disorder | |
| US20150258104A1 (en) | Use of noribogaine for the treatment of pain | |
| EP2892519B1 (en) | Nootropic compositions for improving memory performance | |
| JP2024502304A5 (https=) | ||
| MX2012001814A (es) | Uso de 4-aminopiridina para mejorar la discapacidad neuro - cognoscitiva y/o neuro - psiquiatrica en pacientes con condiciones desmielizantes y otras condiciones del sistema nervioso. | |
| TW201828937A (zh) | 供治療重症肌無力及其他肌無力症候群之用途及組合物 | |
| US9549935B2 (en) | Methods and compositions for treating migraines using noribogaine | |
| US20050203124A1 (en) | Compounds for the sustained reduction of body weight | |
| US20150080448A1 (en) | Combination of 4- benzamide and a nmda receptor antagonist and pharmaceutical compositions containing the same | |
| US20050277664A1 (en) | Monoamine neurotransmitter re-uptake inhibitor for the inhibition of beta-amyloid generation | |
| TW201625253A (zh) | 包含ｐｇｄ２拮抗劑之伴隨過敏性疾病之症狀之治療用醫藥 |